- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PFE
Recent news which mentions PFE
From Benzinga
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
December 12, 2024
From Benzinga
Pfizer's Cancer Drug Ibrance Combo Therapy Extends Median Progression-Free Survival By Over 15 Months In certain Of Breast Cancer Patients
December 12, 2024
From Benzinga
Pfizer's Options: A Look at What the Big Money is Thinking
December 11, 2024
Tickers
PFE
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 11, 2024
From Benzinga
Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients
December 10, 2024
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Pfizer
December 10, 2024
Tickers
PFE
From Benzinga
3 Magnificent S&P 500 Dividend Stock Down 35% to Buy and Hold Forever
December 10, 2024
From Motley Fool
From Motley Fool
Want an Extra $1,000 of Dividend Income in 2025? Invest $11,400 in These 3 High-Yield Stocks.
December 07, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 05, 2024
From Benzinga
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
December 05, 2024
From Motley Fool
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
December 05, 2024
From Motley Fool
Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now.
December 05, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 04, 2024
From Benzinga
Pfizer's New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments
December 03, 2024
From Benzinga
Valneva's Chikungunya Shot Shows Strong, Long-Lasting Antibody Persistence At Three Years, Comparable In Older And Younger Adults
December 03, 2024
From Benzinga
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
From Benzinga
3 Magnificent Dividend Stocks With Yields Above 6% to Buy in December
December 02, 2024
From Motley Fool
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
December 01, 2024
From Motley Fool
Is This a New Reason to Buy Pfizer Stock Hand Over Fist?
November 29, 2024
Tickers
PFE
From Motley Fool
Black Friday Sale for Income Investors: These 3 Ultra-High-Yield Dividend Stocks Are Bargain Buys
November 29, 2024
From Motley Fool
Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead?
November 27, 2024
Tickers
PFE
From Motley Fool
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
From Benzinga
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
November 26, 2024
From Motley Fool
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
November 25, 2024
From Benzinga
3 Dividend Stocks That Are Screaming Buys in November
November 23, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.